Evidence Report
Midwest CEPAC

PDF cover

This is not the most recent version of this material.
For an updated version, please see the relevant topic page.

Atopic Dermatitis: Evidence Report

ICER’s Evidence Report assessing the comparative clinical effectiveness of dupilumab and crisaborole for treatment of atopic dermatitis, along with the comparative value of dupilumab including calculation of value-based price benchmarks.


View All Materials on this Topic or Go Back to View More Materials